Bain Capital Life Sciences Investors, LLC Q4 2024 Filing
Filed February 14, 2025
Portfolio Value
$850.1B
Holdings
26
Report Date
Q4 2024
Filing Type
13F-HR
All Holdings (26 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | NAMSNEWAMSTERDAM PHARMA COMPANY | 10,719,110 | $275.5B | 32.41% | |
| 2 | NUVLNUVALENT INC | 1,447,267 | $113.3B | 13.33% | |
| 3 | PHVSPHARVARIS N V | 3,303,381 | $63.3B | 7.45% | |
| 4 | IRONDISC MEDICINE INC | 983,500 | $62.4B | 7.33% | |
| 5 | DNTHDIANTHUS THERAPEUTICS INC | 2,689,707 | $58.6B | 6.90% | |
| 6 | YB4PSAVARA INC | 14,565,457 | $44.7B | 5.26% | |
| 7 | OLMAOLEMA PHARMACEUTICALS INC | 7,470,214 | $43.6B | 5.12% | |
| 8 | UPBUPSTREAM BIO INC | 2,295,322 | $37.7B | 4.44% | |
| 9 | ANNXANNEXON INC | 5,249,069 | $26.9B | 3.17% | |
| 10 | CDTXCIDARA THERAPEUTICS INC | 703,080 | $18.9B | 2.22% | |
| 11 | SLDBSOLID BIOSCIENCES INC | 4,034,582 | $16.1B | 1.90% | |
| 12 | KYTXKYVERNA THERAPEUTICS INC | 3,368,370 | $12.6B | 1.48% | |
| 13 | ASNSUSDX4 PHARMACEUTICALS INC | 16,915,784 | $12.4B | 1.46% | |
| 14 | —MERSANA THERAPEUTICS INC | 8,663,673 | $12.4B | 1.46% | |
| 15 | TNGXTANGO THERAPEUTICS INC | 2,712,008 | $8.4B | 0.99% | |
| 16 | AVIRATEA PHARMACEUTICALS INC | 2,485,638 | $8.3B | 0.98% | |
| 17 | RPIDRAPID MICRO BIOSYSTEMS INC | 8,434,560 | $7.6B | 0.89% | |
| 18 | CABACABALETTA BIO INC | 2,760,888 | $6.3B | 0.74% | |
| 19 | IPSCCENTURY THERAPEUTICS INC | 5,410,361 | $5.5B | 0.64% | |
| 20 | XLOXILIO THERAPEUTICS INC | 4,566,817 | $4.4B | 0.51% | |
| 21 | CCCCC4 THERAPEUTICS INC | 1,111,910 | $4.0B | 0.47% | |
| 22 | NAUTNAUTILUS BIOTECHNOLOGY INC | 1,759,000 | $3.0B | 0.35% | |
| 23 | MRNS*MARINUS PHARMACEUTICALS INC | 2,693,380 | $1.4B | 0.17% | |
| 24 | NAMSNEWAMSTERDAM PHARMA COMPANY | 100,000 | $1.4B | 0.17% | |
| 25 | IVVDINVIVYD INC | 1,799,595 | $797.4M | 0.09% | |
| 26 | SYRSSYROS PHARMACEUTICALS INC | 2,750,151 | $632.0M | 0.07% |